March 11, 2025
Source: drugdu
27
Tiankang Bio said on the investor interaction platform on March 10 that the company had exported a batch of PPR vaccines to Mongolia a few years ago, and currently has no other overseas sales cases. In the future, the company will continue to pay attention to international market demand, actively evaluate and explore qualified vaccine product export opportunities, and expand its overseas business layout.
https://finance.eastmoney.com/a/202503103341125095.html
By editoryour submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.